Aandeel Pharming Group AEX:PHARM.NL, NL0010391025

quote:

De Monitor schreef op 20 november 2018 10:25:

[...]

Inderdaad. Erg mooi voor de handel wat meer volatiliteit in de koers. Dit wordt een mooie handelsdag.

quote:

De Monitor schreef op 20 november 2018 09:44:

Sijmen heeft gesproken en het aandeel valt als een kaartenhuis in elkaar. Dat is dus nog altijd niet veranderd.
Op naar de 0.70 dus.

quote:

maliqun61 schreef op 20 november 2018 08:42:

[...]

Jongste zoon heeft net kooporder ingelegd: 1000 stuks bestens (openingsveiling).

quote:

Guus_Geluk schreef op 20 november 2018 10:16:

[...]
Goed verhaal van De Vries gisteren.
Dubbele bodem op 0.77 euro
Ben vanmorgen ook weer ingestapt in Pharming.

quote:

LL schreef op 19 november 2018 19:02:

ORLANDO, Fla., Nov. 19, 2018 /PRNewswire/ -- Patients with certain rare, chronic and complex conditions can now obtain the medications that may improve or save their lives from AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy.

The hard-to-find drugs, called limited distribution drugs, treat such rare conditions as metastatic breast cancer, chronic liver disease, metastatic non-small cell lung cancer, and hereditary angioedema, to name a few.

The drugs now available for AllianceRx Walgreens Prime patients include:

Doptelet® (avatrombopag) is used to treat thrombocytopenia (low blood platelet count) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. Manufactured by Dova Pharmaceuticals, this is the first in its class approved by the Food and Drug Administration for this use.
Galafold™ (Migalastat) is the first oral medicine for Fabry disease, a rare, progressive genetic disorder characterized by a defective gene that causes an enzyme deficiency and impacts the kidneys. Manufactured by Amicus Therapeutics, Galafold is the first new therapy approved to treat adult patients with Fabry disease and an amenable galatosidase alpha gene (GLA) variant in the United States in more than 15 years.
Revcovi™ (elapegademase-lvlr), manufactured by Leadiant Biosciences, Inc., treats adenosine deaminase severe combined immune deficiency (ADA-SCID) affecting children and adults. ADA-SCID is caused by a deficiency in the ADA enzyme that is fatal if left untreated. Patients affected by ADA-SCID have compromised immune systems that leave them unprotected from infection-producing bacteria, viruses, and fungi.
Ruconest® (C1 esterase inhibitor [recombinant]), distributed by Pharming Healthcare Inc., is an intravenously infused medicine used to treat acute angioedema (rapid swelling beneath the skin) attacks in adults and adolescents with hereditary angioedema (HAE). HAE, which can be life threatening, is caused by the lack of or dysfunction of a protein called C1 esterase inhibitor, which leads to repeated attacks of swelling in the extremities, abdominal, face, genitals, and/or larynx.
Talzenna™ (talazoparib), manufactured by Pfizer, is used to treat patients who have a certain type of breast cancer (human epidermal growth factor receptor 2 [HER2]-negative), an abnormal inherited BRCA gene, and whose cancer has spread to other parts of the body (locally advanced or metastatic).
Vizimpro® (dacomitnib) treats non-small cell lung cancer that has spread to other parts of the body (metastatic). Also manufactured by Pfizer, Vizimpro is used as a first-line treatment if tumors have certain types of abnormal epidermal growth factor receptor genes.
Zavesca® (miglustat) is used alone to treat adults with mild-to-moderate type 1 Gaucher disease, a genetic condition in which the body lacks the enzyme needed to break down certain fatty materials (lipids). Zavesca is used only in people who cannot be treated with enzyme replacement therapy.

"In our ongoing support of patients with chronic, complex conditions and rare diseases, these additions make it easier for patients to get the medications they need," said Joel Wright, chief executive officer for AllianceRx Walgreens Prime. "While the FDA's approval of these medications supports our purpose of providing hope and care for better tomorrows, access to medication is just part of our treatment approach. Our pharmacists use an integrated care management program to deliver comprehensive and collaborative care for patients throughout their care journey."

About AllianceRx Walgreens Prime
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017 through a collaboration between Walgreens, one of the nation's largest chain drug stores, and Prime Therapeutics, a leading pharmacy benefit manager, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Fla. and its pharmacies are accredited by several national pharmacy accreditation services.

Media Contact
Adrienne Foley | adrienne.foley@alliancerxwp.com | 612.777.6259

SOURCE AllianceRx Walgreens Prime

bron: www.prnewswire.com/news-releases/addi...

buy low sell high

quote:

Declan 2.0 schreef op 20 november 2018 09:46:

[...]

Ja was het maar zo he maar ik waarschuw iedereen nu stap in of accepteer dat je je fout gokte het gaat UP.
Na de klok van 10 is de 70 gezien en komt de 80 kijken.
En nu stoppen met zeuren.

Ruud..

quote:

Tjeerdo schreef op 20 november 2018 10:31:

Denk dat die verzekeraars de doorslag geven bij zo'n grote partij... dan kan je nog zo'n miljardenbedrijf zijn met PR en marketing, als de verzekeraars de voorkeur geven aan het product van de concurrent heb je daar weinig tegenin te brengen...

quote:

watnu schreef op 20 november 2018 10:14:

let op vanmiddag rood dit is elke keer het spel wat gespeeld wordt